{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:52:02Z","timestamp":1793724722576,"version":"4.6.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CORPG3L0471-2"],"award-info":[{"award-number":["CORPG3L0471-2"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["110-2320-B-182A-014-MY3"],"award-info":[{"award-number":["110-2320-B-182A-014-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["110-2326-B-182A-003"],"award-info":[{"award-number":["110-2326-B-182A-003"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2314-B-182A-113-MY3"],"award-info":[{"award-number":["111-2314-B-182A-113-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2326-B-182A-003"],"award-info":[{"award-number":["111-2326-B-182A-003"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 108-2314-B-182A-104 -MY3"],"award-info":[{"award-number":["NSTC 108-2314-B-182A-104 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002836","name":"Chang Gung University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jaut.2023.103054","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T13:28:56Z","timestamp":1684157336000},"page":"103054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines"],"prefix":"10.1016","volume":"138","author":[{"given":"Chuang-Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ti","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaline Chung-Yee","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-Man","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hui","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Chi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Huei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ching","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Yu-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzong-Yun","family":"Ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ting","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ju","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1681-0959","authenticated-orcid":false,"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2023.103054_bib1","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2023.103054_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2023.103054_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2023.103054_bib5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S2213-2600(21)00402-1","article-title":"Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan","volume":"9","author":"Hsieh","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jaut.2023.103054_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jaut.2023.103054_bib7","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2023.103054_bib8","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) covid-19 vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2023.103054_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi6950","article-title":"Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals following mRNA vaccination","volume":"6","author":"Goel","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaut.2023.103054_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjd.20639","article-title":"Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases","volume":"186","author":"Catala","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2023.103054_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2023.103054_bib12","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/all.14761","article-title":"COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: \"Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines\"","volume":"76","author":"Cabanillas","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib13","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1111\/all.14958","article-title":"Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: don't give up on the second dose","volume":"76","author":"Krantz","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jamadermatol.2021.2114","article-title":"Incidence of cutaneous reactions after messenger RNA COVID-19 vaccines","volume":"157","author":"Robinson","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaut.2023.103054_bib15","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/all.14840","article-title":"Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives","volume":"76","author":"Sampath","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib16","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/all.14774","article-title":"Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines","volume":"76","author":"Borgsteede","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jama.2021.0600","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of pfizer-BioNTech COVID-19 vaccine","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2023.103054_bib18","series-title":"Allergies and COVID-19 Vaccines","author":"Barbaud","year":"2022"},{"key":"10.1016\/j.jaut.2023.103054_bib19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/ajt.16517","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021","volume":"21","author":"Shimabukuro","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jaut.2023.103054_bib20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/ajt.16516","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020","volume":"21","author":"Shimabukuro","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jaut.2023.103054_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaci.2012.04.003","article-title":"Adverse reactions to vaccines practice parameter 2012 update","volume":"130","author":"Kelso","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib22","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/jamainternmed.2021.3779","article-title":"Safety evaluation of the second dose of messenger RNA COVID-19 vaccines in patients with immediate reactions to the first dose","volume":"181","author":"Krantz","year":"2021","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jaut.2023.103054_bib23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2021.8515","article-title":"Risk of second allergic reaction to SARS-CoV-2 vaccines: a systematic review and meta-analysis","volume":"182","author":"Chu","year":"2022","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jaut.2023.103054_bib24","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jaci.2022.10.014","article-title":"An update on anaphylaxis and urticaria","volume":"150","author":"Worm","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jaci.2022.08.022","article-title":"Concise update on the pathogenesis of chronic spontaneous urticaria (CSU)","volume":"150","author":"Hide","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib26","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jaci.2022.04.010","article-title":"Autoimmune chronic spontaneous urticaria","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib27","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1111\/all.14839","article-title":"Skin tests in urticaria\/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: limits of intradermal testing","volume":"76","author":"Bianchi","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.anai.2021.03.024","article-title":"Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines","volume":"127","author":"Kelso","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib29","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.7326\/L21-0104","article-title":"Administration of a second dose of the Moderna COVID-19 vaccine after an immediate hypersensitivity reaction with the first dose: two case reports","volume":"174","author":"Mustafa","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2023.103054_bib30","article-title":"Anaphylaxis after the covid-19 vaccine in a patient with cholinergic urticaria","author":"Park","year":"2021","journal-title":"Mil. Med."},{"key":"10.1016\/j.jaut.2023.103054_bib31","volume":"9","author":"Restivo","year":"2021"},{"key":"10.1016\/j.jaut.2023.103054_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.18176\/jiaci.0683","article-title":"Safety of new mRNA vaccines against COVID-19 in severely allergic patients","volume":"31","author":"Rojas-Perez-Ezquerra","year":"2021","journal-title":"J Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/cea.13874","article-title":"Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine","volume":"51","author":"Sellaturay","year":"2021","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib34","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.5415\/apallergy.2021.11.e18","article-title":"Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000","volume":"11","author":"Vieira","year":"2021","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib35","volume":"6","author":"Murayama","year":"2018"},{"key":"10.1016\/j.jaut.2023.103054_bib36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib37","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1111\/jdv.17327","article-title":"Anaphylaxis to vaccination and polyethylene glycol: a perspective from the European Anaphylaxis Registry","volume":"35","author":"Kraft","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jaut.2023.103054_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.anai.2022.01.040","article-title":"We should not abandon the Brighton Collaboration criteria for vaccine-associated anaphylaxis","volume":"129","author":"Blumenthal","year":"2022","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib39","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1016\/j.vaccine.2013.10.050","article-title":"How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria?","volume":"31","author":"Thomas","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2023.103054_bib40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/iid3.125","article-title":"Basophil Activation Test identifies the patients with Chronic Spontaneous Urticaria suffering the most active disease","volume":"4","author":"Curto-Barredo","year":"2016","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaut.2023.103054_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/all.13235","article-title":"Delayed-type hypersensitivity reactions induced by proton pump inhibitors: a clinical and in vitro T-cell reactivity study","volume":"73","author":"Lin","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jbspin.2012.09.010","article-title":"Estrogens and inflammatory autoimmune diseases","volume":"79","author":"Guery","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jaut.2023.103054_bib43","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1196\/annals.1386.043","article-title":"Estrogens and autoimmune diseases","volume":"1089","author":"Cutolo","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2023.103054_bib44","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2017.10.035","article-title":"IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria","volume":"142","author":"Schmetzer","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4168\/aair.2019.11.1.1","article-title":"Anti-TPO IgE autoantibody in chronic urticaria: is it clinically relevant?","volume":"11","author":"Ulambayar","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaut.2023.103054_bib46","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1111\/all.13949","article-title":"Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: results of the PURIST Study","volume":"74","author":"Schoepke","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib47","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/all.13414","article-title":"Executive summary of the methods report for 'the EAACI\/GA(2) LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria. The 2017 revision and update'","volume":"73","author":"Dressler","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1398-9995.2008.01726.x","article-title":"How to assess disease activity in patients with chronic urticaria?","volume":"63","author":"Mlynek","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1398-9995.2011.02580.x","article-title":"Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper","volume":"66","author":"Baiardini","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.anai.2021.10.019","article-title":"Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: northwell Health experience","volume":"128","author":"Kaplan","year":"2022","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib51","doi-asserted-by":"crossref","first-page":"J177","DOI":"10.1016\/j.jaut.2011.11.007","article-title":"Gender differences in autoimmunity associated with exposure to environmental factors","volume":"38","author":"Pollard","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2023.103054_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102468","article-title":"Estrogen, estrogen-like molecules and autoimmune diseases","volume":"19","author":"Merrheim","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2023.103054_bib53","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1080\/15548627.2015.1052206","article-title":"B cell autophagy mediates TLR7-dependent autoimmunity and inflammation","volume":"11","author":"Weindel","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.jaut.2023.103054_bib54","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12016-021-08886-x","article-title":"Chronic urticaria: advances in understanding of the disease and clinical management","volume":"61","author":"He","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib55","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1016\/j.jaip.2021.07.043","article-title":"Autoimmune chronic spontaneous urticaria detection with IgG anti-TPO and total IgE","volume":"9","author":"Kolkhir","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.jaut.2023.103054_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4168\/aair.2022.14.1.131","article-title":"IgE and IgG anti-thyroid autoantibodies in Chinese patients with chronic spontaneous urticaria and a literature review","volume":"14","author":"Zhang","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaut.2023.103054_bib57","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/all.13182","article-title":"Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: a systematic review","volume":"72","author":"Kolkhir","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fncel.2019.00079","article-title":"Thyroid hormone, thyroid hormone metabolites and mast cells: a less explored issue","volume":"13","author":"Landucci","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jaut.2023.103054_bib59","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejim.2007.09.021","article-title":"Skin findings in thyroid diseases","volume":"20","author":"Artantas","year":"2009","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2023.103054_bib60","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1073\/pnas.0701319104","article-title":"Toll-like receptor-MyD88 and Fc receptor pathways of mast cells mediate the thyroid dysfunctions observed during nonthyroidal illness","volume":"104","author":"Rocchi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2023.103054_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.jaut.2023.103054_bib62","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s10067-022-06126-x","article-title":"Systemic lupus erythematous after Pfizer COVID-19 vaccine: a case report","volume":"41","author":"Lemoine","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2023.103054_bib63","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2023.103054_bib64","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jaut.2023.103054_bib65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.imlet.2020.02.003","article-title":"Identification of antigenic epitopes of thyroperoxidase, thyroglobulin and interleukin-24. Exploration of cross-reactivity with environmental allergens and possible role in urticaria and hypothyroidism","volume":"220","author":"Sanchez","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jaut.2023.103054_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061260","article-title":"Immediate hypersensitivity reactions induced by COVID-19 vaccines: current trends, potential mechanisms and prevention strategies","volume":"10","author":"Hung","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaut.2023.103054_bib67","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25524","article-title":"Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system","volume":"4","author":"Warren","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jaut.2023.103054_bib68","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/all.14739","article-title":"EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines","volume":"76","author":"Sokolowska","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2023.103054_bib69","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1111\/jdv.17549","article-title":"Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccine","volume":"35","author":"Smola","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jaut.2023.103054_bib70","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3389\/fimmu.2018.03027","article-title":"Mas-related G protein-coupled receptor-X2 (MRGPRX2) in drug hypersensitivity reactions","volume":"9","author":"Porebski","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112300063X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112300063X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:32:55Z","timestamp":1760257975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089684112300063X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":70,"alternative-id":["S089684112300063X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103054","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103054"}}